End preferential treatment.

Streptokinase for Treatment of Thrombotic Disorders: The End? Or the End of the Beginning?

Thrombotic disorders, such as myocardial infarction, ischemic stroke, peripheral arterial disease, deep venous thrombosis, pulmonary embolism, or other embolic diseases that are responsible for worldwide mortality and morbidity, are manifestations of the formed thrombi by blood clots during a pathologic blood coagulation process. Once thrombi are formed, the only way to resolve the blood clot i...

Hepato‐preferential insulins: Is this the end, or the end of the beginning?

Basal insulin peglispro (BIL) is a novel insulin analogue that binds insulin lispro covalently via a urethane bond to a 20-kDa polyethylene glycol molecule (PEG). This analogue, therefore, has a molecular weight of ~25.8 kDa, approximately three times greater than that of native insulin or most insulin analogues. Its hydrodynamic size, however, appears to be even larger, ~90 kDa, similar to a g...

Sctp Multistreaming: Preferential Treatment among Streams

FCS networks are presented with a new transport layer mechanism that, for transmitting multimedia, is markedly superior to transmission over UDP or TCP. SCTP's multistreaming provides an aggregation mechanism for transferring different objects belonging to the same logical application session; however, sharing the congestion state among the streams precludes efficient stream prioritization. We ...

Preferential and Preferential-discriminative Consequence

The present paper investigates consequence relations that are both paraconsistent and plausible (generally nonmonotonic too). More precisely, we lay the focus on preferential consequence relations, i.e. those relations that can be defined by a binary preference relation on states labelled by valuations (such as in Non-monotonic Reasoning). The first purpose of the paper is to provide characteri...

Preferential treatment for WCB patients angers some MDs.